Brief: Forte Biosciences Q2 basic EPS USD -0.42

Forte Biosciences

14/08/2023 21:55

Aug 14 (Reuters) - Forte Biosciences Q2 operating expenses USD 9.034 million.
* Q2 basic EPS USD -0.42
* Q2 income from operations USD -9.034 million
* Q2 net income USD -8.896 million